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Research
AbstrACt
Objectives To identify and evaluate interventions aimed 
at increasing uptake of, or access to, physical health 
screening by adults with severe mental illness; to examine 
why interventions might work.
Design Realist review.
setting Primary, secondary and tertiary care.
results A systematic search identified 1448 studies, of 
which 22 met the inclusion criteria. Studies were from 
Australia (n=3), Canada (n=1), Hong Kong (n=1), UK 
(n=11) and USA (n=6). The studies focused on breast 
cancer screening, infection preventive services and 
metabolic syndrome (MS) screening by targeting MS-
related risk factors. The interventions could be divided into 
those focusing on (1) health service delivery changes (12 
studies), using quality improvement, randomised controlled 
trial, cluster randomised feasibility trial, retrospective audit, 
cross-sectional study and satisfaction survey designs 
and (2) tests of tools designed to facilitate screening 
(10 studies) using consecutive case series, quality 
improvement, retrospective evaluation and pre–post audit 
study designs. All studies reported improved uptake of 
screening, or that patients had received screening they 
would not have had without the intervention. No estimation 
of overall effect size was possible due to heterogeneity 
in study design and quality. The following factors may 
contribute to intervention success: staff and stakeholder 
involvement in screening, staff flexibility when taking 
physical measurements (eg, using adapted equipment), 
strong links with primary care and having a pharmacist on 
the ward.
Conclusions A range of interventions may be effective, 
but better quality research is needed to determine any 
effect size. Researchers should consider how interventions 
may work when designing and testing them in order to 
target better the specific needs of this population in the 
most appropriate setting. Behaviour-change interventions 
to reduce identified barriers of patient and health 
professional resistance to screening this population are 
required. Resource constraints, clarity over professional 
roles and better coordination with primary care need to be 
addressed.
IntrODuCtIOn 
People with severe mental illness (SMI), such 
as schizophrenia or bipolar disorder, have 
been found to have a twofold to threefold 
increased risk of premature mortality.1 A 
reduction in life expectancy of 10–20 years 
has been reported.2 3 A significant cause of 
this disparity is attributed to preventable and 
treatable long-term physical health condi-
tions, with cardiovascular disease and cancer 
as the first and second leading causes of death, 
respectively, in this group.2 4 Cancer mortality 
in people with SMI is more likely than in the 
general population,5 though the incidence of 
disease is similar for both groups.6 One factor 
which contributes to inequality in survival 
rates is access to cancer screening.7 The 
reported 30% higher case fatality rate from 
cancer may partly be due to those with SMI 
being more likely to present with metastases 
at diagnosis.5 
Other physical health conditions found 
to be more prevalent in people with SMI 
include type 2 diabetes and metabolic 
strengths and limitations of this study
 ► In line with the realist review methodology, a broad 
and inclusive study identification process was used, 
which was adapted iteratively to compensate for the 
inconsistency around how terms such as ‘screening’ 
and ‘monitoring’ are used.
 ► A realist review explores why interventions might 
work in a particular setting, however studies 
provide limited evidence for this, so transferability of 
knowledge to other settings is limited.
 ► A realist review is often selected to understand 
complex interventions, however behaviour change 
theory was not included in almost any intervention 
design, making it impossible to discern which ‘active 
ingredients’ are at work to produce the results.
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syndrome (MS),8 9 tuberculosis, HIV, osteoporosis, poor 
dentition, impaired lung function, sexual dysfunction 
and obstetrical complications.2 MS is defined by the 
WHO10 as glucose intolerance, diabetes mellitus and/
or insulin resistance, with two or more of the following: 
central obesity (waist-to-hip ratio: ≥0.90 in men and ≥0.85 
in women and/or body mass index (BMI) >30 kg/m2), 
raised arterial pressure (≥140/90 mm Hg), microalbu-
minuria (≥20 μg/min or albumin:creatinine ratio ≥30 
μg/mg) and raised plasma triglyceride (≥150 mg/dL 
and/or low high-density lipoprotein cholesterol (HDL-C; 
<35 mg/dL in men and <39 mg/dL in women)).
Health screening facilitates early detection and treat-
ment for many of these conditions, though rates of 
screening in people with SMI may be reduced compared 
with the general population. A UK survey11 found that 
only 33% of people with schizophrenia had received 
adequate cardiovascular disease screening in the previous 
12 months and, internationally, uptake of breast, cervical 
and bowel cancer screening has been found to be lower 
among people with SMI.6 12–15 Effective interventions for 
increasing access to, or uptake of, screening for a range of 
conditions in the general population16 exist. In relation 
to cancer screening, a Cochrane review17 found that no 
intervention to promote uptake has been tested in people 
with SMI. This is important since qualitative work18 indi-
cates there are specific barriers to cancer screening 
uptake in people with SMI and that interventions effec-
tive in the general population may not be effective in 
the SMI population. Furthermore, barriers to screening 
uptake or access may vary for different types of screening, 
at different stages of the screening process and between 
individuals.18
Realist review methodology19 has been devised to 
enable synthesis of diverse literature in order to explore 
what works for whom (as in traditional systematic reviews) 
and why an intervention may work.20
By drawing on this methodology, our objectives were 
to identify and evaluate interventions which may increase 
uptake of, or access to, any kind of physical health 
screening by adults with SMI, and to determine what 
works for whom in what setting and why. The review is 
described in accordance with the Realist And Meta-narra-
tive Evidence Syntheses: Evolving Standards (RAMESES) 
reporting guidance for realist reviews.21
MethODs
study selection
Inclusion and exclusion criteria
Studies of any intervention to promote access to, or 
uptake of, screening or monitoring for any physical 
health condition where participants were aged 18 years 
and over with a diagnosis of SMI (psychosis or bipolar 
disorder however diagnosed) were eligible. Uptake of 
screening was the main outcome of interest. Patient-re-
lated outcomes were not an inclusion criteria, but were 
included in the online supplementary tables following 
the review of the studies, to provide important additional 
information and give a rounded picture of the effective-
ness of the interventions. The UK National Screening 
Committee defines screening as a ‘public health service 
in which members of a defined population…are asked 
a question or offered a test, to identify those individ-
uals who are more likely to be helped than harmed by 
further tests or treatment to reduce the risk of a disease 
or its complications’.22 ‘Monitoring’ was defined in a 
Cochrane23 review as a means ‘to obtain information 
which can then be acted on to treat or prevent a physical 
health problem’. We included any intervention described 
as promoting either screening or monitoring; for clarity 
the term ‘screening’ is used throughout. Only studies 
reported in English were included.
In line with the realist approach to literature synthesis,19 
an inclusive approach was taken and intervention studies 
of any design were eligible as long as the full text was 
published in a peer-reviewed journal. We also excluded 
intervention studies to improve physical health in people 
with SMI which may involve screening, but where uptake 
or access to screening was not a main outcome and service 
evaluations or audits which considered screening, but did 
not test any intervention.
Search strategy
The protocol is published on the International Prospec-
tive Register of Systematic Reviews (PROSPERO) data-
base.24 The search strategy (online supplementary 
appendix 1) was informed by published, related system-
atic reviews8 17 20 and was checked by a specialist health 
librarian at the University of West London (Marc Forster, 
PhD). Searching was conducted in December 2016.
Data sources
MEDLINE, Embase, Cumulative Index to Nursing and 
Allied Health Literature, PsychINFO, Cochrane Database 
of Systematic Reviews, Database of Abstracts of Reviews 
of Effectiveness. Reference chaining of identified studies 
was also conducted. No date restrictions were applied.
search results
The initial electronic search identified 1872 potentially 
relevant publications; six others were identified through 
reference chaining. Titles and abstracts were screened 
independently by two team members (EB and AM). Thir-
ty-three full texts were retrieved and screened by three 
team members (EB, AM, DT). Among the thirty-three 
full texts was a recent systematic review of studies of 
‘Strategies to implement physical health monitoring in 
people affected by severe mental illness’25 which included 
14 studies. Though the focus of this review was slightly 
different from the current, it contained one study which 
we had included.26 It also included two studies which we 
had excluded: one27 was not an intervention study, the 
other tested the validity of a health monitoring tool.28 
This led to a team discussion whereby it was decided that 
studies of interventions, such as health monitoring tools, 
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were relevant to our review question. The rationale being 
that, although the main aim of these interventions was to 
improve the quality of screening (eg, more health indi-
cators measured) and ongoing monitoring, this often 
resulted in increased uptake. We rescreened our iden-
tified studies and those included in this review.25 Forty-
four studies were identified as potentially relevant and 
were screened by two reviewers. Twenty-two of these did 
not meet the inclusion criteria, a total of 22 studies were 
included. The screening and study selection processes 
are detailed in figure 1.
Data extraction
Each reviewer independently extracted information 
from up to five articles, with one author (EB) reviewing 
all studies. Data were extracted regarding study authors, 
geographical location and setting, year of publication, 
participant characteristics, features of the intervention, 
target of screening, outcome measures, study design and 
limitations.
Approach to synthesis
Similarities in intervention approach were identified and 
summarised across studies. Exploration of how and why 
different approaches might have worked was undertaken 
by searching for themes across studies, paying particular 
attention to disconfirming evidence. As there was consid-
erable between-study variation in outcome measures, 
meta-analysis was not possible.
results
study characteristics
Study characteristics are detailed in online supplemen-
tary tables 1 and 2. Two studies29 30 included breast 
cancer screening, one30 considered infection preven-
tive services and 21 studies considered MS screening 
by targeting MS-related risk factors (cholesterol/
sugar),26 28 31–48 blood pressure (BP)26 28–31 33–46 and 
BMI.26 28 30–46 48 Two studies involved national screening 
programmes29 30 and 20 studies developed ‘in-house’ 
screening.26 28 31–48 Study populations included 
Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram of intervention studies included 
in, and excluded from, this review. SMI, severe mental illness.
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participants with schizophrenia,28–31 33–35 37 38 40 44–47 bipolar 
disorder,28–31 33 35 38 44–47 schizoaffective disorder,28 29 31 33 35 44–47 
other psychotic disorders28 30 34 35 38 45 46 and other mental 
health disorders.29–31 33 38 44–46 Some studies did not 
specify the SMI26 39 42 43 while other studies included 
patients with SMI on antipsychotics32 36 41 47 48 with no 
breakdown by condition. Some of the participants in a 
few of the included studies had mental health disorders 
other than SMI. In those studies, there was a minimum 
of 45% participants who had either a psychosis or bipolar 
disorder diagnosis.
A range of study designs was employed (pre–post audit 
n=9, consecutive prospective case series design n=1, repeat 
audit n=1, cross-sectional study n=1, Quality Improve-
ment (QI) n=4, retrospective audit n=4, randomised 
controlled trial n=1, cluster randomised feasibility trial 
n=1). Study quality of randomised trials45 46 was assessed 
using the Cochrane tool49 for assessing risk of bias. No 
similar ‘gold standard’ tool exists which could be used 
across the other study designs, so we assessed each study 
informed by a simple checklist based on the STrength-
ening the Reporting of OBservational studies in Epide-
miology50 statement and a recent review of tools to assess 
bias in observational studies.51 Each study was rated inde-
pendently by two reviewers with discrepancies resolved 
by discussion. Flaws relating to the reliability of findings 
or the generalisability of results were highlighted in all 
studies (online supplementary tables 1 and 2); these data 
suggest that findings concerning the size of effect should 
be considered with caution.
review outcomes
Interventions to increase uptake of screening are defined 
as interventions which support health professionals to 
screen for physical health conditions.28 32–48 Interven-
tions to increase access to screening are defined as inter-
ventions (targeted at health professionals or health 
service delivery) to increase patient/client access to 
screening.26 29–31
Intervention effects
Overall, improvements in rates of screening were reported 
in all studies following intervention (online supplemen-
tary tables 1-2). This appeared to be independent of 
screening type or study design. We identified an evidence 
gap as only three studies31 32 48 reported whether the 
results of screening were acted on, for instance through 
referral or clinical intervention.
Intervention type
Studies broadly either tested a new tool to facili-
tate screening for health professionals28 32 33 35–39 47 
(online supplementary table 1) or made complex health 
services delivery changes26 29–31 40–46 48 (online supple-
mentary table 2). One intervention26 primarily targeted 
service users, though in other studies29 40 44 service user-fo-
cused interventions were included, for instance targeted 
education,33 40 self-management support44 or support to 
attend screening.29 Most studies included staff educa-
tion38 40 43 45 46 48 and training28 33 35 39 42 as part of the 
intervention.
The data-collection tools tested in online supple-
mentary table 1 were designed to gather informa-
tion required to improve MS screening32 33 38 47 or 
physical health monitoring.28 34–37 39 MS monitoring 
was evaluated using the following measurements: BP, 
smoking status, waist circumference (WC), fasting 
blood glucose (BG), BMI, triglycerides and HDL-C. 
These measures were based on the following clinical 
guidelines: National Institute for health and Care 
Excellence26 31 35–37 39–41; Maudsley Prescribing Guide-
lines34 37 40–42; US Preventive Services Task Force30 44; 
National Heart, Lung and Blood Institute33; American 
Diabetes Association32–34 38 47; Early Psychosis Preven-
tion and Intervention Centre43; Psychotropic Ther-
apeutic Guidelines48and the American Psychiatric 
Association Practice.28 35 38 Most interventions were 
multifaceted, so will appear in more than one cluster. 
As no studies were rated of good or moderate quality, 
it was difficult to assess whether findings of improve-
ments in rates of screening are valid. The size of effect 
was not reported for any study.
Screening template
Eight studies28 32–34 36–39 evaluated the effectiveness of using 
a screening tool to increase uptake and raise staff aware-
ness of physical health screening. Barriers to successful 
intervention implementation included ‘social desirability 
bias’28 36 (patients self-report their health behaviour 
in an overly positive picture in an effort to please their 
key workers); low uptake of physical measurements (eg, 
WC,32 37 BP,38 fasting BG33 37) and of data on sensitive 
topics36; difficulty to capture monitoring results onto the 
tool28 32 38 39; difficulty in obtaining equipment37 38 and 
accessing laboratory services33; lack of integration with 
primary care for treatment or referral33 37 38; appointment 
non-adherence32 33; lack of expertise in mental health 
professionals to interpret physical health results34 37; 
workload issues32 33 38; staff reluctant to see MS screening 
as their responsibility.32–34 Authors across studies identi-
fied the following facilitators: investment of staff in phys-
ical health monitoring33 36 37 39 and staff flexibility by using 
alternative equipment and tests.33 39
Staff education and training
Five studies28 33 35 38 39 included staff training as a compo-
nent of the intervention. No author described the content 
or format of education interventions in detail. Barriers to 
successful intervention implementation included work-
load issues33 35 38; lack of training to spot ‘social desirability 
bias’28; lack of training in mean WC measurement.28 The 
following facilitators were identified: ‘booster’ education 
and team meetings33 and investment of staff in physical 
health monitoring.33 39
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Computer or paper prompt for staff
Four studies34 37 39 47 tested a computer-based or paper-
based prompt to support clinicians to monitor and screen 
physical health indicators. Barriers to the successful 
implementation of the intervention included tech-
nical constraints in terms of collecting measurement 
results39 47; low uptake of physical measurements (eg, WC37 
and fasting BG37 47); lack of expertise from mental health 
professionals to interpret physical health results34 37; 
unclear communication channel between primary and 
secondary care34 37 and limited access to equipment and 
resources.34 37 Having a clinical psychiatric pharmacist on 
the ward to remind clinicians to request investigations, 
such as blood tests when appropriate, and to provide the 
relevant guidelines and precautions when initiating hypo-
lipidaemic medication, was a facilitator to the successful 
implementation of the intervention in two studies.37 47
Online supplementary table 2 describes 12 studies 
which tested interventions that delivered change in a 
health service setting. Most interventions were multi-
faceted so appear in more than one cluster. All studies 
targeted adults, though in one study42 eligible participants 
were 14–35 years old. Studies took place in a clozapine 
clinic,48 Early Intervention in Psychosis Services,41–43 
Community Mental Health Team (CMHT),31 44 45 commu-
nity drop-in centre29 and primary care.26 30 Interventions 
were focused on metabolic/cardiovascular screening for 
all studies, except one29 which was designed to increase 
rates of mammography uptake. One study30 monitored 
uptake of national cancer screening services and meta-
bolic screening. The size of effect was not reported for 
any study. All studies reported suboptimal screening and 
monitoring at baseline, with improved levels postinter-
vention. However, limited evidence of actions, such as 
referral or intervention, occurring as a result of these 
improvements was reported.
Staff education and training
Six studies40 42 43 45 46 48 provided some kind of staff (working 
in primary and secondary care) and patient education. All 
studies described increased rates of monitoring following 
the interventions. One study45 was rated as good quality, 
so generalisation of results is limited. Barriers to the 
successful implementation of the intervention included 
staff time constraints40 48; poor communication across 
the primary and secondary care interface43 45 and lack 
of clarity over scope of practice48; patient resistance to 
undergo physical measurements42 46; staff resistance to 
change40 45 46 and staff turnover.43 46 Facilitators included 
team ownership and team ‘champions’ to encourage 
screening40 42 and high visibility/structure around moni-
toring and better liaison with primary care.42 48
Invitation letter to physical health screening
Three studies26 40 42 used an invitation letter from primary 
care to encourage patients to attend screening as part of a 
physical health check-up. All studies described increased 
rates of monitoring following the interventions. Barriers 
to the successful implementation of the intervention 
included patient resistance to undergo physical measure-
ments42 and staff resistance to change.40 Facilitators 
included team40 42 ownership and team ‘champions’ to 
encourage screening; getting stakeholders involved40 42 
and living in a suburban26 (rather than urban) area.
Improving access to monitoring resources
Four studies41 43 46 48 tested interventions developed to 
improve the collection of physical health data to increase 
screening. Barriers to the successful implementation of 
the intervention included patient resistance and lack 
of motivation in the screening process41 46; inadequate 
links with primary care41 43; no clarity about who takes 
responsibility for screening41 48; staff turnover43 46; staff 
not perceiving physical health screening as a priority41 46; 
time and resource (screening equipment) constraints41 48; 
poor recording and knowledge of screening guidelines 
and tests.41 48 Facilitators included high visibility and 
structure around monitoring48 and having a key worker 
system with key worker’s duties involving screening.41
Integrating care across health settings
Seven studies29–31 40 42 44 45 were developed to evaluate 
and reduce the fragmentation of care between different 
care providers. New clinics to improve physical health-
care were set up and evaluated,29–31 two trials44 45 evalu-
ated nurse-led care management and two studies audited 
improvement in awareness42 and communication40 
within the multidisciplinary care coordination team. All 
reported improvement in physical health monitoring or 
uptake of screening tests postintervention. Two studies44 45 
were rated as good quality. One study44 reported improve-
ment in cardiovascular disease risk among intervention 
subjects of an effect size comparable with that seen in 
underserved populations without mental illness. Barriers 
to the successful implementation of the intervention 
included lack of coordination across the primary and 
secondary care interface30 45; patient reluctance to attend 
appointment/undergo screening29 42; staff resistance to 
change40 45 and lack of a prescribing provider.44 Facil-
itators included team investment in screening proce-
dure and stakeholder involvement29 31 40 42; psychosocial 
support and trust between patients and staff to help 
them obtain screening29 44 and availability of primary and 
specialist care.29 30 42 45
Staff accompaniment to appointments
Four studies29 33 40 44 included accompaniment of service 
users to appointments as part of their intervention. This 
type of intervention addresses potential difficulties in 
locating and visiting unfamiliar places which has been 
reported as a barrier to cancer screening uptake by some 
service users.18 One study33 from online supplementary 
table 1 was added to this cluster as it included staff accompa-
niment to screening. Barriers to the successful implementa-
tion of the intervention included staff workload issues33 40; 
difficulty to engage staff33 40; patient reluctance to undergo 
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screening29 33 and difficulty to obtain an appointment/
appointment non-adherence.29 33 Facilitators included staff 
feeling invested/having a sense of ownership with regard to 
physical health screening29 33 40; having access to primary 
care/in-home phlebotomy services29 33 44 and trust between 
clients and staff.29 33
DIsCussIOn
statement of principal findings
A large international body of work was identified with 
diversity in the number of physical health conditions and 
clinical settings. Challenges to increase uptake of phys-
ical health screening and monitoring in people with SMI 
was not unique to a particular country, setting or health 
service configuration. The studies illustrate that people 
with SMI come into contact with a number of different 
health services. Two tools to facilitate screening35 39 and two 
health service delivery change26 40 interventions were deliv-
ered in primary care. The remaining took place in inpa-
tient and outpatient mental health services. Mental health 
staff performed ‘in-house’ screening,28 31 36 37 43 46 48 ordered 
screening tests30–34 38 41–43 45 47 or acted as a broker between 
the patient and screening service.29 33 41 44 Overall, there 
appears to be no strong evidence as to whether an inter-
vention to increase uptake of screening would be better 
suited in primary or secondary care. Performing ‘in-house’ 
screening in mental health services rather than in a primary 
care context warrants further research, including what 
training and equipment this requires. In addition, mech-
anisms to establish and maintain strong links between 
primary care/screening clinics and mental health services 
to ensure patients attend screening appointments appear 
central to monitoring patients’ physical health.
Identified barriers to the successful implementation 
of tools to facilitate screening can be clustered into 
resource constraints, environmental barriers, unclear 
boundaries around professional role and a perceived 
lack of professional skills and training. Authors in several 
studies33 34 37–39 47 noted a number of logistical and resource 
constraints to the successful collection of measurements 
due to limited staff time32 33 35 38 and difficulty accessing 
monitoring equipment (such as specific WC tool for obese 
patients and access to BP monitors in CMHTs). Staff also 
reported difficulties capturing monitoring results onto 
the tool28 32 38 39 (eg, complicated guidelines to follow). 
Other barriers included patient resistance to exploring 
sensitive topics such as sexual health, and transporta-
tion, cultural and language barriers to access phlebotomy 
clinics and arranging an appointment.
Authors in several studies32 33 36–38 47 noted low uptake 
of physical measurements (eg, WC, fasting BG) and 
appointment non-adherence to cancer screening and 
MS monitoring. Lack of integrated care between mental 
health services and primary care33 34 37 38 for treatment 
and referral postdiagnosis was another barrier. Some 
mental health staff were reluctant to see MS screening 
as their responsibility,32 33 leading to resistance to engage 
in this activity. The lack of training to collect WC data 
in a uniform way, and unawareness of a potential ‘social 
desirability bias’,28 36 lead to the risk of unreliable results. 
Lastly, a perceived lack of expertise from mental health 
professionals to interpret physical health results34 37 was 
raised as a potential barrier.
Several facilitators to the successful implementation 
of tools to facilitate screening were identified, including 
staff feeling invested and having a sense of ‘ownership’ 
in physical health monitoring,33 36 37 39 staff flexibility 
around taking measures by using alternative equipment 
and tests33 39 and having a clinical psychiatric pharma-
cist37 47 on the ward to support mental health profes-
sionals, for example, by reminding staff to request blood 
tests and provide the relevant guidelines and precautions 
to follow when hypolipidaemic agents are prescribed.
Barriers to the successful implementation of health 
service delivery changes are clustered into resource 
constraints, environmental barriers, unclear boundaries 
around professional role and patient resistance. Authors 
note lack of time33 40 47 for health professionals to allocate 
to screening as a barrier, as well as staff turnover43 46 and 
other resource constraints41 44 47 such as lack of screening 
equipment and a prescribing provider. Environmental 
barriers include lack of coordination across the primary 
and secondary care interface30 41 43 45 and difficulty for 
patients and staff to obtain a screening appointment.29 33 
Reluctance to engage in screening was observed from 
the clinician and patient perspective. In staff, limited 
clarity over who takes responsibility for screening41 48 
was a barrier, as well as difficulty to engage staff33 40 in 
the project, staff resistance to change40 45 46 and staff not 
perceiving physical health screening as a priority.41 46 In 
patients, reluctance to engage with screening was iden-
tified as lack of motivation/scepticism in the screening 
process,41 46 appointment non-adherence29 33 42 and 
particular resistance to undergo physical measure-
ments.42 46
Facilitators to the successful implementation of health 
service delivery changes include having team ‘champions’ 
or a key worker to encourage screening, having staff that 
feel invested/a sense of ownership with regard to phys-
ical health screening,29 33 40–42 47 stakeholder involve-
ment,29 31 40 42 having strong links to primary care and 
specialist services29 30 33 42 45 48 including at-home phle-
botomy services and established trust between clients 
and staff.29 33 44 Barriers to the successful implementation 
of tools and health service delivery changes to facilitate 
screening include workload issues, resource constraints 
such as difficulty accessing monitoring equipment, 
patient resistance to screening and difficulty in arranging 
an appointment, fragmented links between primary and 
secondary care, unclear professional role boundaries for 
screening and staff resistance to engage in screening. 
Facilitators to the successful implementation of tools and 
health service delivery changes to facilitate screening 
include staff feeling invested and a sense of ‘ownership’ 
to engage in physical health monitoring.
 o
n
 28 M
arch 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-019412 on 10 February 2018. Downloaded from 
 7Lamontagne-Godwin F, et al. BMJ Open 2018;8:e019412. doi:10.1136/bmjopen-2017-019412
Open Access
The quality of data identified was generally low, it is 
therefore not possible to determine the size of effect any 
intervention may have. Different interventions may target 
different aspects of screening and different barriers and 
facilitators may apply. However, the high level of hetero-
geneity and the limited quality of evidence meant that it is 
not possible to draw firm conclusions. Several potentially 
useful intervention approaches were identified however. 
A key aim of this review was to identify what approach 
worked for whom. However, this was not achieved since 
few studies tested this. Nevertheless, the review identified 
specific barriers and facilitators to screening uptake or 
access in people with SMI which should be considered in 
future studies.
Future studies should be reported using the Template 
for Intervention Description and Replication (TIDiER) 
guidelines52 and Medical Research Council53 guidance to 
make explicit how the components of complex interven-
tions may work. Similarly, use of behaviour change theory 
was considered in one intervention design43—some studies 
acknowledged it was not considered—which provides no 
insight into what might have impacted on staff and service 
user behaviour to increase uptake. Only few interventions 
were designed in collaboration with service users, and their 
preferences were not explored.
There are no longitudinal studies; therefore, this review 
is unable to clarify if screening is maintained postinter-
vention, and whether the increase in uptake is sustain-
able or a consequence of the Hawthorne effect whereby 
health professional behaviour reacts to being observed. 
An evidence gap was identified as only three studies31 32 46 
reported on whether the results of screening were acted 
upon, for instance through referral or clinical interven-
tion. One study33 aims to make annual MS screening a 
‘routine responsibility’ for the mental health team but 
acknowledges it cannot refer patients to primary care.
study limitations
There is inconsistency around how terms such as 
‘screening’ and ‘monitoring’ are used which hampers 
comparative exercises. Our method of deploying them 
may differ to that of others who may use different terms 
and include different studies. To compensate for this, 
and in line with realist review methodology, we used a 
broad and inclusive study identification process which we 
adapted iteratively through the study selection process, 
as described in the Study Selection section. We identified 
a wide range of studies with varied participants, settings, 
interventions and intervention targets; a narrower review 
may provide answers which are more applicable to partic-
ular situations; however, the lack of good quality evidence 
identified suggests that this is unlikely to be the case.
COnClusIOn
Policy implications
Interventions to reduce patient and health professional 
resistance to screening which are informed by behaviour 
change theory should be developed and tested. Strategies 
to improve coordination between primary and secondary 
care are also needed, as are guidelines to clarify profes-
sional role boundaries. Resource constraints such as staff 
time and lack of monitoring equipment in mental health 
settings need to be addressed in the various clinics where 
screening occurs. Involving service users in intervention 
design is also important so that their preferences for loca-
tion, frequency and type of support can be identified and 
targeted. Consideration of how interventions are likely to 
work should be made during development and testing.
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